ClinicalTrials.gov
ClinicalTrials.gov Menu

Study the Role of Genetic Variation in the Determining Lipid Profile Response to Dietary Change

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00673023
Recruitment Status : Completed
First Posted : May 7, 2008
Last Update Posted : May 7, 2008
Sponsor:
Information provided by:
Tabriz University

Brief Summary:
The purpose of this study is to determine whether plasma lipoproteins and lipid responsiveness to a dietary modification is influenced by CETP gene polymorphism.

Condition or disease Intervention/treatment Phase
Metabolic Syndrome Other: Dietary experiments Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 102 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Basic Science
Official Title: Study the Role of Polymorphism at the CETP Gene Locuse in the Determining Lipid Profile Response to Dietary Change
Study Start Date : October 2007
Actual Primary Completion Date : December 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: 1 Other: Dietary experiments
Dietary Supplement: high PUFA diet followed by high SFA diet
Experimental: 2 Other: Dietary experiments
Dietary Supplement: high PUFA diet followed by high SFA diet
Experimental: 3 Other: Dietary experiments
Dietary Supplement: high PUFA diet followed by high SFA diet




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Healthy Volunteers

Exclusion Criteria:

  • History of any cardiovascular diseases
  • type 1 diabetes
  • type 2 diabetes
  • use of lipid-lowering medications
  • hypertension
  • pregnancy
  • Current intake of vitamins and supplements
  • History of endocrin disorder

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00673023


Sponsors and Collaborators
Tabriz University
Investigators
Study Director: Mohammad Noori, PhD Tabriz University

Responsible Party: vice-chancellor for reseach, Tabriz University, Deputy of Research
ClinicalTrials.gov Identifier: NCT00673023     History of Changes
Other Study ID Numbers: 8641
First Posted: May 7, 2008    Key Record Dates
Last Update Posted: May 7, 2008
Last Verified: May 2008

Additional relevant MeSH terms:
Metabolic Syndrome X
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases